Cargando…
EGFR突变影响非小细胞肺癌PD-L1表达的研究进展
Researches on the inhibitors of programmed death-1 (PD-1) and programmed death-1 ligand (PD-L1) enjoy considerable breakthroughs in recent years, which has brought relative changes in the therapeutic model of non-small cell lung cancer (NSCLC) at an unexpected speed. However, it seems that PD-1/PD-L...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935036/ https://www.ncbi.nlm.nih.gov/pubmed/31874674 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.12.08 |